Matthew Ros - See Remarks, Epizyme, Inc

As of August 18, 2021


Matthew Ros Net Worth

  • Net worth is estimated to be at least $3.83M
  • Owns at least 83,188 units of Epizyme, Inc stock
  • Sold an estimated value of $3.8M in the last 5 years at Epizyme, Inc

Matthew Ros Compensation at Epizyme, Inc in 2020

  • Earned a $447,982 salary
  • Received a total compensation of $1,634,789

Matthew Ros Trading

  • Largest purchase of shares was 112,003 units , worth over $1.06M on June 22, 2020
  • Largest sale of shares was 112,003 units , worth over $2.38M on June 22, 2020
  • In total has made about 16 transactions over 5 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Matthew Ros Mailing Address

  • Mailing address is C/o Epizyme, Inc. 400 Technology Square Cambridge MA 02139 MA

Epizyme, Inc Executive Compensation

Name
Year
Salary
Bonus
Restricted Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert B. Bazemore Jr. 2020 $650,000 - $3,237,620 $4,103,853 $370,500 $96,369 $8,458,342
Robert B. Bazemore Jr. 2019 $592,937 - $1,105,393 $2,060,531 $409,127 $5,630 $4,173,618
Robert B. Bazemore Jr. 2018 $575,667 - - $2,748,939 $320,575 $5,690 $3,650,871
Paolo Tombesi 2020 $460,000 - $250,006 $750,730 $174,800 $48,198 $1,683,734
Paolo Tombesi 2019 $168,901 - $612,848 $1,173,669 $76,076 $146,971 $2,178,465
Matthew E. Ros 2020 $447,982 - $250,006 $750,730 $174,800 $11,271 $1,634,789
Matthew E. Ros 2019 $432,600 - $538,793 $899,137 $199,861 $11,598 $2,081,989
Matthew E. Ros 2018 $420,000 - - $1,099,576 $187,100 $12,214 $1,718,890
Dr. Shefali Agarwal 2020 $478,000 - $274,990 $825,799 $199,804 $7,154 $1,785,747
Dr. Shefali Agarwal 2019 $463,500 - $894,607 $1,255,325 $265,122 $8,652 $2,887,206
Dr. Shefali Agarwal 2018 $199,615 $125,000 - $1,472,846 $200,500 $1,648 $1,999,609
Jeffery L. Kutok, M.D., Ph.D. 2020 $337,500 $85,000 $374,996 $1,124,996 $134,663 $6,813 $2,063,968
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm

Epizyme, Inc Insider Trading

  • The most recent transaction was 1,780 units sold on December 7, 2021 by Shefali Agarwal worth over $5.22K
  • In the last 8 years, insiders at Epizyme, Inc sold an estimated value of $153.27M and bought an estimated value of $343.67M
  • The most active traders are David Mott, Director,  Robert Copeland, President Research and CSO,  and Andrew Singer, EVP & CFO
  • Insider trading is most common in June, with the busiest year in 2014
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1